Discover a study that also highlighted that treatment intensification with enzalutamide benefited patients regardless of ...

The aggressiveness of a cancer is based on several factors, including the tumor's grade and stage, and the cells' genetic ...

New research reveals prostate cancer survivors face a significant long-term risk of developing a third primary cancer, with a ...

Astellas and Pfizer's Xtandi plus ADT showed a decrease in mortality risk in a metastatic hormone-sensitive prostate cancer ...

Joe Biden’s cancer diagnosis has raised big questions about his health and future. At 82, the former president is battling ...

EXCLUSIVE: A leading authority in prostate treatment and urology has given his insights on a condition that can affect 1 in 8 ...

Former United States president Joe Biden has been forced to clarify his cancer timeline following the Donald Trump cover-up ...

Spatial transcriptomics may transform prostate cancer research by mapping immune cell localization and gene expression in ...

In the largest clinical genomic profiling study of non-Hispanic Black men with metastatic prostate cancer to date, researchers from Moffitt Cancer Center, University of Pennsylvania, University of ...

New research has identified specific blood-based biomarkers that can predict the failure of prostate cancer treatment in both hormone-sensitive and castration-resistant patients.